Labshake search
Citations for R&D Systems :
51 - 100 of 10000+ citations for L β Homo β 2 hydroxyphenyl glycine; R 3 Amino 3 2 hydroxyphenyl propanoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2023Quote: ... cells were treated with IFN-β (R&D Systems #8499-IF-010 ...
-
ADAR2 deaminase activity promotes Th17 effector function and protects against intestine inflammationbioRxiv - Immunology 2022Quote: ... 0.1-0.3 ng/mL TGF-β (R&D Systems), and 20 ng/mL IL-6 (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... IL-23 and TGF-β from R&D Systems, anti-IFN-γ from U-CyTech and anti-IL-4 from BD Pharmingen ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Cell Biology 2020Quote: ... as mesoderm and β-III tubulin (R&D Systems, MAB1195) as ectoderm marker.
-
bioRxiv - Immunology 2021Quote: ... and/or TGF-β (2.0 ng/ml; R&D Systems) and retinoic acid (RA ...
-
bioRxiv - Neuroscience 2021Quote: ... goat anti-PDGFR-β (1:500, #AF1042 R&D Systems), rat anti-CD206 (1:200 ...
-
bioRxiv - Immunology 2021Quote: ... and/or 0.1 ng/mL TGF-β (R&D Systems), 20 ng/mL IL-1β (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (10 ng/mL) (both from R&D Systems), all-trans retinoic acid (ATRA ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (10 ng/mL; R&D Systems 240-B002), IL-23 (10 ng/mL ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (5ng/ml; carrier-free; Tocris R&D Systems), anti-IFNγ antibody (2 ug/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... anti-PDGFR-β antibody (1:100, AF1042, R&D Systems), anti-smooth muscle actin antibody (1:500 ...
-
bioRxiv - Biochemistry 2022Quote: ... with human recombinant nerve growth factor β (R&D Systems) and with bovine histone III (Sigma-Aldrich) ...
-
bioRxiv - Molecular Biology 2022Quote: ... anti-β-III tubulin (1:125; R&D Systems, MAB1195), anti-α smooth muscle actin (1:250 ...
-
bioRxiv - Bioengineering 2022Quote: ... and Mouse IFN-β Duoset ELISA kit (R&D systems) were purchased for ELISA experiments ...
-
bioRxiv - Molecular Biology 2023Quote: ... Recombinant human IFN-β (R&D Systems #8499-IF-010) treatment was used to induce RIG-I expression and to correctly select clones with the lowest RIG-I level ...
-
bioRxiv - Molecular Biology 2023Quote: ... IL-1 β (50 U/ml; R&D Systems, USA), IFN-α (2000 U/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... for mural cells against PDGFR-β (R&D Systems, AF1042), NG2 (Sigma AB5320A4) ...
-
bioRxiv - Immunology 2024Quote: ... Recombinant human INF-β were obtained from R&D systems. The anti-Myc magnetic beads (Clone 9E10 ...
-
bioRxiv - Neuroscience 2024Quote: ... for mural cells against PDGFR-β (R&D Systems, AF1042), CD13 (Acris Antibodies ...
-
bioRxiv - Bioengineering 2022Quote: ... α3 (MAB1345; R&D systems), β4 (NBP1-43369) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 3 (R&D Systems); coenzyme Q10 (CoQ) ...
-
bioRxiv - Microbiology 2022Quote: ... IFN-β amounts in the culture supernatant were measured by human IFN-β ELISA kit (R&D Systems, DIFNB0) according to the manufacturer’s protocol.
-
bioRxiv - Neuroscience 2022Quote: ... and Neurotrophin-3 (NT-3, 20ng/ml, R&D systems) were used for neural differentiation between days 27 and 41 ...
-
bioRxiv - Microbiology 2023Quote: The levels of secreted IFN-β were measured by an IFN-β enzyme-linked immunosorbent assay (ELISA) (R&D Systems) following the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2023Quote: ... IFN-β amounts in the culture supernatant were measured by the human IFN-β ELISA kit (R&D Systems, DIFNB0) according to the manufacturer’s protocol.
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3) were purchased from R&D Systems.
-
bioRxiv - Cancer Biology 2022Quote: ... human interleukin-3 (IL-3, 10 ng/mL, R&D Systems), human interleukin-6 (IL-6 ...
-
bioRxiv - Molecular Biology 2021Quote: ... human soluble β-klotho (5889-KB-050/CF, R&D Systems), human FGFR1c (658FR050) ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Microbiology 2020Quote: ... IFN-β (500 U/ml, R&D systems 8499-IF-010) or IFN-γ (200 U/ml ...
-
bioRxiv - Molecular Biology 2020Quote: ... TGF-β and VEGF-A with specific ELISA (R&D Systems) according to the manufacturer’s instructions.
-
bioRxiv - Immunology 2021Quote: ... TGF-β (30 ng/ml; carrier-free; Tocris R&D Systems), IL-6 (30 ng/ml ...
-
bioRxiv - Biochemistry 2022Quote: ... recombinant human nerve growth factor-β (R&D Systems, Minneapolis, MIN); LysM (from Enterococcus faecalis ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 ng/mL rmTGF-β (R&D Systems, #7666-MB-005), and 10 ng/mL rhFGF2 (R&D Systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... The following proteins were analyzed: TGF-β (FCSTM17, R&D Systems), CCL2 and TNF (HCYTOMAG ...
-
bioRxiv - Microbiology 2023Quote: ... IFN-β (500 U/ml, R&D systems 8499-IF-010) or IFN-γ (200 U/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... and IFN-β (DY8234; R&D Systems Incorporated, Minneapolis, MN, USA). Using the collected RAW264.7 lysate ...
-
bioRxiv - Immunology 2023Quote: ... anti-VEGF and anti-TGF-β detection antibodies (R&D Systems) diluted in BSA 1% (1:1000) ...
-
bioRxiv - Neuroscience 2024Quote: ... anti-β-III tubulin 1:100 (R&D Systems, MAB1195-SP), anti-GFAP 1:100 (Cell Signaling ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
bioRxiv - Developmental Biology 2024Quote: ... 3 µM CHIR (R&D Systems), 10 mM A83-01 (Tocris ...
-
bioRxiv - Developmental Biology 2024Quote: ... SSEA-3 (R&D Systems, MAB1434) and Alexa Fluor 594 conjugated SSEA-4 (BioLegend ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 mM L-glutamine and 20 ng/ml BDNF (R&D Systems). In each group (control and Celsr2 mutant) ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant interferon-β (IFNβ) (8324-MB) was purchased from R&D Systems. It was reconstituted it at 100 μg/mL in sterile PBS containing 0.1% BSA and injected (i.p. ...
-
bioRxiv - Cancer Biology 2022Quote: ... or 20ng/ml recombinant TGF-β (R&D Systems, 7666-MB-005) for 5-6 d before processing and analysis by described assays.